Riverside-backed Decera Clinical invests in healthcare knowledge platform Onviv
- Riverside invested in Decera Clinical in 2020
- Jeff Meehan serves as founder and CEO of Onviv
- Onviv was founded in 2015
Decera Clinical, which is backed by The Riverside Company, has invested in Onviv Inc, a Morristown, New Jersey-based healthcare knowledge and expert network platform. No financial terms were disclosed.
Based in Reston, Virginia, Decera Clinical is a provider of continuing education for medical professionals.
On the investment, Peter Tsang, co-chief investment officer, Riverside Capital Appreciation Fund (RCAF), said in a statement, “This reflects our continued commitment to investing in differentiated, mission-aligned businesses positioned at the intersection of healthcare, technology, data and human expertise. Decera Clinical and Onviv each bring unique strengths and strong market positions, and together they are exceptionally well-positioned for continued growth, innovation and long-term value creation.”
Riverside invested in Decera Clinical in 2020.
Jeff Meehan serves as founder and CEO of Onviv.
Excel Partners acted as exclusive financial advisor to Onviv, Inc.
Onviv was founded in 2015.
